These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 21472149)

  • 1. Triple therapy: boon or bane for high-risk CV patients?
    Phillippe HM; Baty SR; Griffith CB
    J Fam Pract; 2011 Apr; 60(4):187-92. PubMed ID: 21472149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prasugrel for acute and long-term treatment of patients with acute coronary syndromes: what is state-of-the-art?].
    Silber S; Helms TM; Garlichs C; Arntz HR; Weil J; Ince H; Klingenheben T; Hoffmann S; Boudriot E; Steiger H; Zugck C
    Dtsch Med Wochenschr; 2011 Apr; 136(15):782-5. PubMed ID: 21432747
    [No Abstract]   [Full Text] [Related]  

  • 3. Current oral antiplatelets: focus update on prasugrel.
    John J; Koshy SK
    J Am Board Fam Med; 2012; 25(3):343-9. PubMed ID: 22570398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute coronary syndromes: identifying the appropriate patient for prasugrel.
    Stephens JC; Askari AT
    Postgrad Med; 2012 Mar; 124(2):16-28. PubMed ID: 22437212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prasugrel as antiplatelet therapy in patients with acute coronary syndromes or undergoing percutaneous coronary intervention.
    Fletcher B; Thalinger KK
    Crit Care Nurse; 2010 Oct; 30(5):45-54. PubMed ID: 20889512
    [No Abstract]   [Full Text] [Related]  

  • 6. [Using ADP receptor antagonists in coronary heart disease and acute coronary syndrome].
    Schreiber P; Fauchère I; Wyss C
    Praxis (Bern 1994); 2014 Sep; 103(18):1049-58. PubMed ID: 25183612
    [No Abstract]   [Full Text] [Related]  

  • 7. Triple therapy in hospitalized patients: facts and controversies.
    Srour JF; Smetana GW
    J Hosp Med; 2011 Nov; 6(9):537-45. PubMed ID: 21374797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 9. Advances in antiplatelet therapy for acute coronary syndromes.
    Contractor H; Ruparelia N
    Postgrad Med J; 2012 Jul; 88(1041):391-6. PubMed ID: 22357775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V; Marín F
    Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
    [No Abstract]   [Full Text] [Related]  

  • 11. Prasugrel for the treatment of coronary thrombosis: a review of pharmacological properties, indications for use and future development.
    Tomasello SD; Tello-Montoliu A; Angiolillo DJ
    Expert Opin Investig Drugs; 2011 Jan; 20(1):119-33. PubMed ID: 21143003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of antiplatelet therapy in the secondary prevention of coronary artery disease.
    Behan MW; Chew DP; Aylward PE
    Curr Opin Cardiol; 2010 Jul; 25(4):321-8. PubMed ID: 20386440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of switching 'hyper responders' from Prasugrel to Clopidogrel after acute coronary syndrome: the POBA (Predictor of Bleeding with Antiplatelet drugs) SWITCH study.
    Deharo P; Pons C; Pankert M; Bonnet G; Quilici J; Grosdidier C; Beguin S; Morange P; Alessi MC; Bonnet JL; Cuisset T
    Int J Cardiol; 2013 Oct; 168(5):5004-5. PubMed ID: 23915522
    [No Abstract]   [Full Text] [Related]  

  • 14. Is it appropriate to compare the results from two clinical trials with one drug in common?
    Marrugat J; Vila J; Elosua R
    Rev Esp Cardiol (Engl Ed); 2013 Feb; 66(2):151-3. PubMed ID: 24775396
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiplatelet drug use in patients with non-ST-segment elevation acute coronary syndromes.
    Aronow WS
    Postgrad Med; 2013 Jan; 125(1):51-8. PubMed ID: 23391671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prasugrel: newest antiplatelet agent and its emerging role in management of acute coronary syndrome and percutaneous coronary intervention.
    Robinson A; Das K; Koshy SK; Das P
    Future Cardiol; 2009 May; 5(3):237-46. PubMed ID: 19450050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?
    Huber K; Bates ER; Valgimigli M; Wallentin L; Kristensen SD; Anderson JL; Lopez Sendon JL; Tubaro M; Granger CB; Bode C; Ohman EM; Steg PG
    Am Heart J; 2014 Nov; 168(5):611-21. PubMed ID: 25440788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facts and controversies of aspirin and clopidogrel therapy.
    Faxon DP; Freedman JE
    Am Heart J; 2009 Mar; 157(3):412-22. PubMed ID: 19249409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Conversations in cardiology": How do you pick the best antiplatelet drug--clopidogrel, prasugrel, ticagrelor for your PCI patient?
    Kern MJ
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):255-62. PubMed ID: 22271555
    [No Abstract]   [Full Text] [Related]  

  • 20. Prasugrel offers consistent platelet control in appropriate patients requiring treatment.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(2):107, 109. PubMed ID: 21556460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.